Build-time findings tell you that vulnerable code or packages exist somewhere in the artifact or source path. Runtime-verified findings tell you the vulnerable component is actually active in a running workload. That distinction matters because release gates should prioritise flaws that are both real and reachable, not every theoretical issue detected before deployment.
What build-time findings actually tell you
Build-time findings answer a source-path question: does the artifact, image, package tree, or codebase contain a vulnerable version or dependency? That is useful for hygiene, provenance, and release review, but it can overstate operational exposure if the component is never loaded, called, or reachable in production. Treat it as evidence of presence, not proof of exploitable runtime risk.
In practice, build-time signals are strongest when you want to stop known-bad components before they ship, SLSA is a useful anchor for thinking about build provenance and artifact integrity. The key limitation is that a scanner can only see what is packaged, not whether the vulnerable code path is actually exercised under real workload conditions.
That means build-time findings are often broad by design. They are excellent for inventory, policy enforcement, and early warning, but they usually need another decision layer before you treat them as release blockers. If the finding sits in dead code, an unused package, or a component that is compiled in but functionally unreachable, its practical risk can be far lower than the scanner output suggests.
What runtime-verified findings add
Runtime-verified findings show that the vulnerable component is not just present, it is active in a running service, container, VM, or workload. That makes the finding materially stronger because it ties the weakness to a live attack surface, not just a theoretical dependency chain. Runtime evidence is therefore closer to exposure, exploitability, and potential business impact.
This distinction matters most in containerized and cloud-native environments, where a build artifact can contain many transitive packages but only a subset are ever loaded. A runtime lens is what separates “present in the image” from “reachable in production,” which is why runtime-oriented guidance such as NIST SP 800-190 Container Security is helpful when you need to reason about image, orchestrator, and workload behavior together.
Runtime verification also improves prioritisation. If a vulnerable library is confirmed to be loaded by a production process, or a vulnerable endpoint is exposed and exercised, that finding deserves faster remediation than an identical issue that only exists in a dormant artifact path. In other words, runtime verification turns static vulnerability data into operationally relevant exposure data.
How to use both signals in release decisions
The best release gate does not choose between the two, it sequences them. Use build-time findings to catch and remove obvious defects early, then use runtime verification to decide which issues are actually reachable, exploitable, or worth an immediate exception. That approach prevents teams from blocking releases on every theoretical issue while still keeping real exposure visible.
- Prioritise findings that are both present and active in production paths.
- Treat build-time-only findings as candidates for cleanup, exception, or deferred remediation based on exposure and control coverage.
- Escalate immediately when runtime verification confirms a vulnerable component in a high-trust or internet-reachable workload.
For teams with mature software assurance practices, this is where supply-chain and delivery controls intersect with operational security. OWASP SAMM helps frame the process side, while SLSA helps frame artifact trust, but runtime verification is what keeps prioritisation grounded in what is actually deployed.
Risk and Threat Considerations
Build-time findings create risk when teams mistake artifact presence for operational exposure, or when they treat every scanner hit as equally urgent. Runtime-verified findings create a more serious condition because they confirm an active attack surface that may be reachable by users, attackers, or internal callers.
Failure mechanism: A vulnerable component may be packaged into an artifact but never execute, while a runtime-verified component is loaded, invoked, or exposed in a live path. The failure is not the vulnerability itself, it is the mismatch between where the weakness exists and whether the environment can actually exercise it.
Impact: Build-time-only findings can waste remediation effort and delay releases; runtime-verified findings increase the likelihood of exploitability, so they should move faster through triage, exception handling, and patch planning.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
SLSA, CIS Controls v8 and NIST SP 800-190 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| SLSA | Build provenance and integrity | Build-time findings depend on artifact provenance and dependency integrity. |
| Recommendation — Verify artifact provenance before treating build-time findings as release-blocking evidence. | ||
| CIS Controls v8 | CIS-7 — Continuous Vulnerability Management | The question is about prioritising findings and reducing false-positive remediation work. |
| Recommendation — Rank remediation by reachability and exposure, not scanner volume alone. | ||
| NIST SP 800-190 | Application Container Security Guide | Runtime-verified findings in containerized workloads depend on image and workload exposure. |
| Recommendation — Validate runtime exposure in containers before escalating image-only findings. | ||
Practitioner Guidance
What to verify: Confirm whether the vulnerable component is loaded in the production execution path, exposed over a network boundary, or reachable only in a non-production code path. If the scanner cannot answer that, pair it with runtime evidence before deciding on severity.
Decision rule: If the issue is build-time only, classify it as inventory or hygiene work unless the component is clearly on a critical path. If runtime verification proves active use, treat it as a live exposure and prioritise it accordingly.
Practitioner takeaway: The real question is not whether a flaw exists somewhere in the artifact, it is whether production can actually execute it under conditions an attacker could reach.
Related resources from NHI Mgmt Group
- What is the difference between runtime threat detection and build-time vulnerability context in container security?
- What is the difference between build-time policy enforcement and runtime enforcement for coding assistants?
- What is the difference between build-time and runtime security for AI agents?
- What is the difference between securing workloads at build time and securing them at runtime in hybrid cloud environments?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 30, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
